Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121276 |
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2018-04-12 | 2018-05-16 | 45533 |
MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
MINT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121279 |
MINT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46030 |
MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
MINT-QUETIAPINE | 200MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46038 |
MINT-QUETIAPINE | 300MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46041 |
MINT-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35492 |
MINT-SOLIFENACIN | 10MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35495 |
MINT-LEVOCARB | 10MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32263 |
MINT-LEVOCARB | 25MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32270 |
MINT-LEVOCARB | 25MG 250MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32274 |
MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
MINT-HYDRALAZINE | 10MG | TABLET | Resolved | 2019-02-28 | 2019-09-03 | 77148 |
MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-24 | 2019-12-09 | 89913 |
MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-09 | 2019-11-29 | 95947 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |